Haemonetics Corporation APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Haemonetics Corporation (HAE) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $9.31 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06
- Haemonetics Corporation apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-27 was $9.31M, a 0.01% decline year-over-year.
- Haemonetics Corporation apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-27 was $7.80M, a 5.05% decline year-over-year.
- Haemonetics Corporation apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-27 was $7.59M, a 10.68% increase year-over-year.
- Haemonetics Corporation apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-28 was $9.31M, a 22.08% increase year-over-year.
- Haemonetics Corporation apic, share-based payment arrangement, increase for cost recognition for fiscal 2026 was $33.83M, a 14.14% increase from fiscal 2025.
- Haemonetics Corporation apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $29.64M, a 4.60% increase from fiscal 2024.
- Haemonetics Corporation apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $28.33M, a 10.75% increase from fiscal 2023.
- Haemonetics Corporation apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $25.58M, a 5.02% increase from fiscal 2022.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|---|
| 2026-06-27 | $9.31M 10-Q · filed 2026-08-06 | ||||
| 2026-03-28 | $33.83M 10-K · filed 2026-05-20 | ||||
| 2025-12-27 | $7.80M 10-Q · filed 2026-02-05 | $15.39M derived: sum of 2 quarters · filed 2026-02-05 | $24.70M derived: sum of 3 quarters · filed 2026-08-06 | ||
| 2025-09-27 | $7.59M 10-Q · filed 2026-02-05 | $16.90M derived: sum of 2 quarters · filed 2026-08-06 | |||
| 2025-06-28 | $9.31M 10-Q · filed 2026-08-06 | ||||
| 2025-03-29 | $29.64M 10-K · filed 2025-05-21 | ||||
| 2024-12-28 | $8.21M 10-Q · filed 2026-02-05 | $15.07M derived: sum of 2 quarters · filed 2026-02-05 | $22.70M derived: sum of 3 quarters · filed 2026-02-05 | ||
| 2024-09-28 | $6.86M 10-Q · filed 2026-02-05 | $14.48M derived: sum of 2 quarters · filed 2026-02-05 | |||
| 2024-06-29 | $7.63M 10-Q · filed 2026-02-05 | ||||
| 2024-03-30 | $28.33M 10-K · filed 2026-05-20 | ||||
| 2023-12-30 | $7.22M 10-Q · filed 2025-02-06 | $13.92M derived: sum of 2 quarters · filed 2025-02-06 | $20.91M derived: sum of 3 quarters · filed 2025-02-06 | ||
| 2023-09-30 | $6.71M 10-Q · filed 2025-02-06 | $13.70M derived: sum of 2 quarters · filed 2025-02-06 | |||
| 2023-07-01 | $6.99M 10-Q · filed 2025-02-06 | ||||
| 2023-04-01 | $25.58M 10-K · filed 2025-05-21 | ||||
| 2022-12-31 | $7.49M 10-Q · filed 2024-02-08 | $13.23M derived: sum of 2 quarters · filed 2024-02-08 | $18.52M derived: sum of 3 quarters · filed 2024-02-08 | ||
| 2022-10-01 | $5.74M 10-Q · filed 2024-02-08 | $11.03M derived: sum of 2 quarters · filed 2024-02-08 | |||
| 2022-07-02 | $5.30M 10-Q · filed 2024-02-08 | ||||
| 2022-04-02 | $24.36M 10-K · filed 2024-05-20 | ||||
| 2022-01-01 | $6.46M 10-Q · filed 2023-02-07 | $12.43M derived: sum of 2 quarters · filed 2023-02-07 | $19.26M derived: sum of 3 quarters · filed 2023-02-07 | ||
| 2021-10-02 | $5.98M 10-Q · filed 2023-02-07 | $12.81M derived: sum of 2 quarters · filed 2023-02-07 | |||
| 2021-07-03 | $6.83M 10-Q · filed 2023-02-07 | ||||
| 2021-04-03 | $25.52M 10-K · filed 2023-05-22 | ||||
| 2020-12-26 | $6.29M 10-Q · filed 2022-02-08 | $12.24M derived: sum of 2 quarters · filed 2022-02-08 | $18.41M derived: sum of 3 quarters · filed 2022-02-08 | ||
| 2020-09-26 | $5.95M 10-Q · filed 2022-02-08 | $12.12M derived: sum of 2 quarters · filed 2022-02-08 | |||
| 2020-06-27 | $6.17M 10-Q · filed 2022-02-08 | ||||
| 2020-03-28 | $20.45M 10-K · filed 2022-05-25 | ||||
| 2019-12-28 | $5.33M 10-Q · filed 2021-02-02 | $10.32M derived: sum of 2 quarters · filed 2021-02-02 | $15.05M derived: sum of 3 quarters · filed 2021-02-02 | ||
| 2019-09-28 | $5.00M 10-Q · filed 2021-02-02 | $9.73M derived: sum of 2 quarters · filed 2021-02-02 | |||
| 2019-06-29 | $4.73M 10-Q · filed 2021-02-02 | ||||
| 2019-03-30 | $17.19M 10-K · filed 2021-05-26 | ||||
| 2018-12-29 | $4.73M 10-Q · filed 2020-08-04 | $4.78M 10-Q · filed 2019-02-05 | $9.31M derived: sum of 2 quarters · filed 2020-08-04 | $12.69M derived: sum of 3 quarters · filed 2020-08-04 | |
| 2018-09-29 | $4.58M 10-Q · filed 2020-02-04 | $7.96M derived: sum of 2 quarters · filed 2020-02-04 | |||
| 2018-06-30 | $3.38M 10-Q · filed 2020-02-04 | ||||
| 2018-03-31 | $13.03M 10-K · filed 2020-05-20 | ||||
| 2017-04-01 | $9.15M 10-K · filed 2019-05-22 | ||||
| 2016-04-02 | $6.95M 10-K · filed 2018-05-23 | ||||
| 2015-03-28 | $14.10M 10-K · filed 2017-05-24 | ||||
| 2014-03-29 | $13.08M 10-K · filed 2016-06-01 | ||||
| 2013-03-30 | $10.97M 10-K · filed 2015-05-22 | ||||
| 2012-03-31 | $9.29M 10-K · filed 2014-05-22 | ||||
| 2011-04-02 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-20 | $6.72M derived: sum of 2 quarters · filed 2013-05-20 | $8.61M derived: sum of 3 quarters · filed 2013-05-20 | $10.81M 10-K · filed 2013-05-20 | |
| 2011-01-01 | $4.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-02-08 | $5.95M derived: sum of 2 quarters · filed 2011-02-08 | $8.14M 10-Q · filed 2011-02-08 | ||
| 2010-10-02 | $1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-11-10 | $4.09M 10-Q · filed 2010-11-10 | |||
| 2010-07-03 | $2.20M 10-Q · filed 2010-08-11 | ||||
| 2010-04-03 | $10.27M 10-K · filed 2012-05-22 | ||||
| 2009-03-28 | $10.18M 10-K · filed 2011-05-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |